Inozyme
Inozyme is a provider of therapies for rare diseases of calcification affecting soft tissues and bone created to offer potentially disease-modifying therapies to help children who are affected with rare, but severe and debilitating disorders of metabolism. The company's enzyme replacement therapy provides the treatment of Generalized Arterial Calcification of Infancy (GACI) and Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2), enabling patients to treat diseases characterized by mineral imbalances in the body.
Domain
inozyme.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$60.0M
Founded
2015
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Inozyme use?+
Inozyme uses 11 technologies including SeedProd Coming Soon, WordPress, jQuery.
What industry is Inozyme in?+
Inozyme operates in the Biotechnology industry.
Where is Inozyme based?+
Inozyme is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026